Related Experiment Videos

[Primary pulmonary hypertension in children]

Zeitschrift Fur Kardiologie
|November 1, 1982
PubMed

Insights

This case report details an infant diagnosed with primary pulmonary hypertension at 12 months, showing rapid right-ventricular hypertrophy. Despite treatment, the infant succumbed to the condition, with histopathology confirming the diagnosis.

Area of Science:

  • Pediatric Cardiology
  • Pulmonary Hypertension Research
  • Infant Cardiovascular Health

Background:

  • Primary pulmonary hypertension (PPH) is a rare and severe condition affecting infants.
  • Early diagnosis and intervention are critical for managing pediatric cardiovascular diseases.
  • Understanding the progression of PPH in infants is crucial for developing effective treatments.

Observation:

  • A 12-month-old infant, under cardiological observation since birth, presented with symptoms of primary pulmonary hypertension.
  • Echocardiography revealed rapidly progressing right-ventricular hypertrophy.
  • Cardiac catheterization confirmed pulmonary hypertension without congenital heart defects.

Findings:

  • The infant's condition rapidly worsened, indicating aggressive disease progression.
  • Standard treatments, including isoproterenol and tolazoline, proved ineffective.
  • Histopathological examination post-mortem supported the diagnosis of primary pulmonary hypertension.

Implications:

  • This case highlights the aggressive nature and poor prognosis of primary pulmonary hypertension in infants.
  • It underscores the need for novel therapeutic strategies for pediatric pulmonary hypertension.
  • Further research into the pathophysiology of PPH in neonates and infants is warranted.

Related Concept Videos